Correlation Between Anoto Group and Moberg Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Anoto Group and Moberg Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anoto Group and Moberg Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anoto Group AB and Moberg Pharma AB, you can compare the effects of market volatilities on Anoto Group and Moberg Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anoto Group with a short position of Moberg Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anoto Group and Moberg Pharma.

Diversification Opportunities for Anoto Group and Moberg Pharma

-0.37
  Correlation Coefficient

Very good diversification

The 3 months correlation between Anoto and Moberg is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Anoto Group AB and Moberg Pharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Moberg Pharma AB and Anoto Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anoto Group AB are associated (or correlated) with Moberg Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Moberg Pharma AB has no effect on the direction of Anoto Group i.e., Anoto Group and Moberg Pharma go up and down completely randomly.

Pair Corralation between Anoto Group and Moberg Pharma

Assuming the 90 days trading horizon Anoto Group AB is expected to under-perform the Moberg Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Anoto Group AB is 1.36 times less risky than Moberg Pharma. The stock trades about -0.02 of its potential returns per unit of risk. The Moberg Pharma AB is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  1,673  in Moberg Pharma AB on October 4, 2024 and sell it today you would lose (656.00) from holding Moberg Pharma AB or give up 39.21% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Anoto Group AB  vs.  Moberg Pharma AB

 Performance 
       Timeline  
Anoto Group AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Anoto Group AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Moberg Pharma AB 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Moberg Pharma AB are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain fundamental drivers, Moberg Pharma unveiled solid returns over the last few months and may actually be approaching a breakup point.

Anoto Group and Moberg Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Anoto Group and Moberg Pharma

The main advantage of trading using opposite Anoto Group and Moberg Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anoto Group position performs unexpectedly, Moberg Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moberg Pharma will offset losses from the drop in Moberg Pharma's long position.
The idea behind Anoto Group AB and Moberg Pharma AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume